GlassScriptPhysician profile
Raul R Blanco
NPI 1134303498
$2,642.22
in general payments reported to CMS, 2019-2025
19 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $277 · 2020: $64.43 · 2021: $23.45 · 2022: $366 · 2023: $791 · 2024: $415 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,555 · Consulting Fee: $356.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,555.09 |
| Consulting Fee | $355.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $943.92 | 2022-2025 | Ffrct |
| Novartis Pharmaceuticals Corporation | $525.14 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $318.90 | 2019-2023 | Magnetom Sola, Acuson Sc2000 Diagnostic Ultrasound System, Biograph Horizon-3r |
| Abbott Laboratories | $137.52 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $130.32 | 2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $102.70 | 2019-2024 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $98.12 | 2023-2025 | Farxiga |
| Boston Scientific Corporation | $69.03 | 2020-2024 | Varithena Administration Pack |
| Inspire Medical Systems, INC. | $56.75 | 2025 | Inspire |
| Lantheus Medical Imaging, INC. | $49.99 | 2019 | |
| Bracco Diagnostics INC. | $37.65 | 2022 | |
| Amgen INC. | $29.99 | 2025 | Repatha |
| Janssen Scientific Affairs, LLC | $29.59 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.42 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.06 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18.03 | 2023 | Rybelsus, Ozempic |
| Pfizer INC. | $17.54 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.55 | 2021 | |
| Medtronic, INC. | $14.00 | 2024 | Venaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raul Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.